Recruiting studies: Evans Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Anti-CD38 Antibody Treating Evans Syndrome
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT06014775 Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
Phase 2 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04993885 A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC
Phase 2 · 5 location(s) · Novartis Pharmaceuticals · NCT07421167 Sirolimus in the Treatment of Refractory/Relapsed wAIHA
NA · 1 location(s) · Peking Union Medical College Hospital · NCT05925023 A Study of CM336 in Patients With Relapsed or Refractory Autoimmune Cytopenia
Phase 1/Phase 2 · 3 location(s) · Keymed Biosciences Co.Ltd · NCT07175493 UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases
EARLY_Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT07441525 OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia
Phase N/A · 9 location(s) · University Hospital, Bordeaux · NCT05937828

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.